Join
Live feed
·
INSIDERFilingvia Quantisnow
Eagle Pharmaceuticals Inc. logo

SEC Form 4: Tarriff Scott covered exercise/tax liability with 3,113 shares and was granted 70,900 shares, increasing direct ownership by 4% to 1,639,934 units (withholding tax)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EGRX (Eagle Pharmaceuticals Inc.) and more on Quantisnow.